We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 17 investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Docandu is an innovative digital health platform designed both for patients & doctors, making digital healthcare accessible from anywhere. Docandu aims to be a key tech health service provider, starting from Greece, improving the existing national and private health care services. The global digital health market is estimated to be worth $536 Billion by 2025. To date, they have developed two separate apps for doctors and patients. They have also received an angel investment of 100,000 Euros and sponsorship of $25,000 from Microsoft. The company has initiated early-stage relationships with a couple of Greek public and private health entities. With the proceeds, they will execute their go-to-market strategy and make global health ID a reality, by expanding its affiliate network of doctors, health providers and public health systems.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £70,900
nHouse is a disruptive housing company that builds beautiful eco-friendly homes offsite in the UK. It makes houses by using modular methods wherein individual parts of a house are constructed separately in a factory before being transported and assembled together at the building site. The company's houses have Buildoffsite Property Assurance Scheme (BOPAS) accreditation; they are mortgage friendly and have a 60-year structural warranty. They have a demand of 300,000 houses every year in the UK. Major UK newspapers like the FT, The Times, The Guardian, and The Sun have covered nHouse's work. In 2025, the company is aiming to generate a return for shareholders via either a listing or trade sale. The investment will support working capital to extend the runway of nHouse into 2021.
days to go: Expired investment: £147,480
MyHomeGroup Ltd. is the UK's top online Estate Agency Group. It is the home for all property related transactions and offers various services including selling, renting and managing the property. The company has created a world-class team and non-executive board and advisors from organisations such as Specsavers, Procter & Gamble, and The House Crowd. MyHomeGroup's SellMyHome and RentMyHome are rated 9.8/10 on Trustpilot. Furthermore, the company has also witnessed over 8,000 registrations across the platforms. The proceeds will be used to develop technology, establish geographic and horizontal market opportunities and create a world-class C-Level team.
days to go: Expired investment: £615,699
Brickowner is a service provider for property developers and asset managers wanting to improve the cost and efficiency of onboarding and managing investors. The company undertakes crucial tasks related to property transactions such as Anti Money Laundering (AML), Know Your Client (KYC), investor categorisation, and escrow requirements for its clients. These tasks take a lot of time and money through regular offline channels, but the company speeds up this process by taking it online. In 2017, a sum of £348,000 was invested through the company's platform which by January 2020 had reached over £12 million. The company has over 2400 investors registered on its platform wherein 630+ investors have invested in substantial investments. It has been featured in prominent publications such as Daily Mail, Property Week, London Evening Standard, and The Week. The company will use the investment aims to cover capital costs to support growth such as hiring, develop new technology to increase product availability, marketing strategy, and increase the technical capacity of the platform.
days to go: Expired investment: £397,840
Jupiter Diagnostics provide a patent-protected portable reader and test card to provide reliable and cost-effective blood results. Each test card has the ability to measure multiple tests from a prick of blood from the finger and can deliver laboratory-quality results in just ten minutes.
days to go: Expired investment: £2,005,050
By combining fitness with fashion, art and design, BLOK has become a major competitor of boutique class-based gyms within London. BLOK has appeared on Britain's Next Top Model, as well as working with global stars including Anthony Joshua and Jordan Dunn.

Pitch Rated

60%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £891,790
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph